Kwang Nho

Title: Innovations of Kwang Nho in Blood Substitute Technology.

Introduction

Kwang Nho is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical engineering, particularly in the development of blood substitutes. His innovative work focuses on enhancing the safety and efficacy of hemoglobin derivatives.

Latest Patents

Kwang Nho holds a patent for a hemoglobin derivative co-conjugated with fatty acid-linked polyethylene glycol (FA-PEG) and alkoxy polyethylene glycol (alkoxy-PEG) as a blood substitute. This invention relates to a method for creating a hemoglobin derivative that exhibits non-toxicity and extended intravascular retention time. The patent highlights various embodiments, including crosslinked hemoglobin that is co-conjugated with both FA-PEG and alkoxy-PEG derivatives.

Career Highlights

Kwang Nho is currently associated with Sun Bio, Inc., where he continues to advance research in blood substitute technologies. His work has the potential to revolutionize transfusion medicine and improve patient outcomes.

Collaborations

Kwang Nho collaborates with talented individuals in his field, including Minjung Ahn and Changmin Hyun. Their combined expertise contributes to the innovative projects at Sun Bio, Inc.

Conclusion

Kwang Nho's contributions to the development of hemoglobin derivatives as blood substitutes demonstrate his commitment to advancing medical technology. His innovative approach has the potential to significantly impact the field of transfusion medicine.